Skip to main content
  • Home
  • Articles
    • Archive from 2022 July
    • Archive 1960 to 2022 June
    • Accepted Articles
    • Published Ahead-of-Print
    • Supplement
  • About
  • For Authors
  • Podcasts

Production of a polyclonal antibody against osteogenic protein-1, and its role in the diagnosis of osteoarthritis

< Back to Listing

Share this Article

Singapore Med J 2014; 55(7): 388-391; http://dx.doi.org/10.11622/smedj.2014092
Production of a polyclonal antibody against osteogenic protein-1, and its role in the diagnosis of osteoarthritis

  • Abstract
  • PDF
  • References

Bhutia SC, Singh TA, Sherpa ML
Correspondence: Dr Mingma Lhamu Sherpa, mingmals@yahoo.com

ABSTRACT
INTRODUCTION Osteoarthritis (OA) is a progressive degenerative disorder of the articular cartilage. Available diagnostic radiography has been poorly associated with the progress and severity of this clinical disease. As osteogenic protein-1 (OP-1) has been identified as a bone morphogenetic protein with a major role in cartilage repair, we aimed to evaluate its potential role in the diagnosis of OA.
METHODS This was an experimental study conducted at the Department of Biochemistry, Sikkim Manipal Institute of Medical Sciences, India. Polyclonal antibodies (i.e. anti-OP-1[f]) were raised against OP-1 in mice, and subsequently used in a sandwich enzyme-linked immunosorbent assay (ELISA) to detect the presence of OP-1 in the synovial fluids of 75 osteoarthritic patients. For the purpose of correlation, the radiographic assessments of the knees of the 75 patients were graded using the Kellgren-Lawrence scoring system.
RESULT The polyclonal antibody (i.e. anti-OP-1[f]) raised against OP-1 was able to detect the presence of OP-1 in the synovial fluids of all the osteoarthritic patients via sandwich ELISA. The level of the OP-1 was found to be much higher than the reference range and correlated positively with the severity of OA (r = 0.24; p = 0.04).
CONCLUSION Our study shows that the polyclonal antibody, anti OP-1(f), could be used for the immunodiagnosis of osteoarthritis via sandwich ELISA.

Keywords: osteoarthritis, osteogenic protein-1, sandwich ELISA, synovial fluid
Singapore Med J 2014; 55(7): 388-391; http://dx.doi.org/10.11622/smedj.2014092

http://smj.org.sg/sites/default/files/5507/5507a7.pdf

REFERENCES

1. Hayashi M, Muneta T, Ju YJ, Mochizuki T, Sekiya I. Weekly intra-articular injections of bone morphogenetic protein-7 inhibits osteoarthritis progression. Arthritis Res Ther 2008; 10:R118.
http://dx.doi.org/10.1186/ar2521
 
2. Chambers MG, Bayliss MT, Mason RM. Chondrocyte cytokine and growth factor expression in murine osteoarthritis. Osteoarthritis Cartilage 1997; 5:301-8.
http://dx.doi.org/10.1016/S1063-4584(97)80034-9
 
3. Sharma MK, Swami HM, Bhatia V, et al. An epidemiological study of correlates of osteoarthritis in geriatric population of UT Chandigarh. IndianJ Community Med 2007; 32:77-8.
http://dx.doi.org/10.4103/0970-0218.53414
 
4. Lawrence JS, Bremner JM, Bier F. Osteo-arthrosis. Prevalence in the population and relationship between symptoms and x-ray changes. Ann Rheum Dis 1966; 25:1-24.
PMid:5905334 PMCid:PMC2453365
 
5. Loeser RF. Age-related changes in the musculoskeletal system and the development of osteoarthritis. Clin Geriatr Med 2010; 26:371-86.
http://dx.doi.org/10.1016/j.cger.2010.03.002
 
6. Moskowitz R, Goldberg V, Vowell DS, Altman RD, Buckwalter J. Noninvasive markers in osteoarthritis. Osteoarthritis: Diagnosis and Medical/Surgical Management. 3rd ed. Philadelphia: Saunders, 2001: 293-313.
 
7. Chubinskaya S, Hurtig M, Rueger DC. OP-1/BMP-7 in cartilage repair. Int Orthop 2007; 31:773-81.
http://dx.doi.org/10.1007/s00264-007-0423-9
 
8. Desmyter S, Goubau Y, Benahmed N, de Wever A, Verdonk R. The role of bone morphogenetic protein-7 (Osteogenic Protein-1) in the treatment of tibial fracture non-unions. An overview of the use in Belgium. Acta Orthop Belg 2008; 74:534-7.
PMid:18811040
 
9. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986; 29:1039-49.
http://dx.doi.org/10.1002/art.1780290816
 
10. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957; 16:494-502.
http://dx.doi.org/10.1136/ard.16.4.494
 
11. Avrameas S. Coupling of enzymes to proteins with glutaraldehyde. Use of the conjugates for the detection of antigens and antibodies. Immunochemistry 1969; 6:43-52.
http://dx.doi.org/10.1016/0019-2791(69)90177-3
 
12. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979; 76:4350-4.
http://dx.doi.org/10.1073/pnas.76.9.4350
 
13. Shapiro AL, Vi-uela E, Maizel JV Jr. Molecular weight estimation of polypeptide chains by electrophoresis in SDS-polyacrylamide gels. Biochem Biophys Res Commun 1967; 28:815-20.
http://dx.doi.org/10.1016/0006-291X(67)90391-9
 
14. Guellaen G, Goodhardtt M, Hanoune J. Preparative SDS gel electrophoresis. In: J Craigventer, L Harrison, eds. Receptor purification procedures. New York: Alan R Liss, 1984; 2:109-24.
 
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-75.
PMid:14907713
 
16. Committee for the Purpose of Control and Supervision on Experiments on Animals. CPCSEA Guidelines For Laboratory Animal Facility [online]. Available at: http://icmr.nic.in/bioethics/final_cpcsea.pdf. Accessed November 12, 2012.
 
17. Cheirmaraj K, Reddy MV, Harinath BC. Diagnostic use of polyclonal antibodies raised in mouse ascitic fluid in bancroftian filariasis. J Immunoassay 1990; 11:429-44.
http://dx.doi.org/10.1080/01971529008055043
 
18. Reddy MV, Prasad GB, Harinath BC. Isolation and evaluation of antigens from microfilaraemia plasma and immune complexes for diagnosis of bancroftian filariasis. Indian J Pathol Microbiol 1986; 29:179-88.
PMid:3546110
 
19. Collins DH. The Pathology of Articular and Spinal Diseases. Edward Arnold: London Osteoarthritis, 1949: 74-115.
 
20. Chubinskaya S, Kumar B, Merrihew C, et al. Age-related changes in cartilage endogenous osteogenic protein-1 (OP-1). Biochim Biophys Acta 2002; 1588:126-34.
http://dx.doi.org/10.1016/S0925-4439(02)00158-8
 
21. Merrihew C, Kumar B, Heretis K, et al. Alterations in endogenous osteogenic protein-1 with degeneration of human articular cartilage. J Orthop Res 2003; 21:899-907.
http://dx.doi.org/10.1016/S0736-0266(03)00055-X
 
22. Chubinskaya S, Merrihew C, Cs-Szabo G, et al. Human articular chondrocytes express osteogenic protein-1. J Histochem Cytochem 2000; 48:239-50.
http://dx.doi.org/10.1177/002215540004800209
 
23. Honsawek S, Chayanupatkul M, Tanavalee A, et al. Relationship of plasma and synovial fluid BMP-7 with disease severity in knee osteoarthritis patients: a pilot study. Int Orthop 2009; 33:1171-5.
http://dx.doi.org/10.1007/s00264-009-0751-z
 
24. Rueger DC, Chubinskaya S. BMPs in articular cartilage repair. In: Vukicevic S, Sampath KT, eds. Bone morphogenetic proteins: regeneration of bone and beyond. Birkhauser: Basel, 2004: 109-32.
http://dx.doi.org/10.1007/978-3-0348-7857-9_5
 
25. Chubinskaya S, Frank BS, Michalska M, et al. Osteogenic protein 1 in synovial fluid from patients with rheumatoid arthritis or osteoarthritis: relationship with disease and levels of hyaluronan and antigenic keratan sulfate. Arthritis Res Ther 2006, 8:R73.
http://dx.doi.org/10.1186/ar1947
×

Around the Site

Home

About SMJ

For Reviewers

Sign Up for Alerts

Issues

Current Issue

All Issues

Online First

Supplement

CME

For Authors

Instructions for Authors

Submit Manuscript


Follow us on:
        

More Links

Contact Us

Copyright

Advertise

SMJ Forms

Privacy Policy

SMA Home

Copyright 2021. Singapore Medical Association. All Rights Reserved.